Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Chemmedchem|May 17, 2024
Synthesis of α-Hydroxy-1,2,3-Triazole-linked Sialyltransferase Inhibitors and Evaluation of Selectivity Towards ST3GAL1, ST6GAL1 and ST8SIA2Rémi Szabo, Chris Dobie, Andrew P Montgomery, et al.Journal of Medicinal Chemistry|October 7, 2022
Recent Scaffold Hopping Applications in Central Nervous System Drug DiscoveryTimothy B Callis, Taylor R Garrett, Andrew P Montgomery, et al.Bioorganic & Medicinal Chemistry|July 4, 2020
Design, synthesis and evaluation of carbamate-linked uridyl-based inhibitors of human ST6Gal IAndrew P Montgomery, Christopher Dobie, Rémi Szabo, et al.Trends in Pharmacological Sciences|October 17, 2024
Enhancing CNS mitophagy: drug development and disease-relevant modelsKrishayant S Dhar, Brendan Townsend, Andrew P Montgomery, et al.International Journal of Molecular Sciences|April 30, 2021
DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem CellsBrianna Chen, Dylan McCuaig-Walton, Sean Tan, et al.Frontiers in Chemistry|May 3, 2024
Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by pieceBill W G L Chan, Nicholas B Lynch, Wendy Tran, et al.International Journal of Molecular Sciences|December 11, 2022
Understanding In Vitro Pathways to Drug Discovery for TDP-43 ProteinopathiesHei W A Cheng, Timothy B Callis, Andrew P Montgomery, et al.RSC Medicinal Chemistry|March 10, 2025
PK 11195 derivatives: exploring the influence of amide and heterocyclic substitution on A147T TSPO discriminationRenee Sokias, Andrea Zhao, Eryn L Werry, et al.ACS Chemical Neuroscience|July 27, 2023
Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET RadioligandsAnnukka Kallinen, Karine Mardon, Samuel Lane, et al.European Journal of Medicinal Chemistry|September 13, 2020
Tricyclic heterocycles display diverse sensitivity to the A147T TSPO polymorphismRenee Sokias, Eryn L Werry, Hei Wun Alison Cheng, et al.Pageof 3